Diagnosis of Arrhythmias in Syncope by Pocket-ECG III® or Conventional Holter

Syncope Clinical Trial

— SINPocket  

Official title:

Diagnosis of Arrhythmias in Patients With Syncope by Continuous Cardiac Telemetry (Pocket-ECG III® System) or Conventional Holter

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02614235
• Other study ID #: EP-CHUAC-01
• Status: Completed
• Phase: N/A
• First received: November 23, 2015
• Last updated: July 16, 2017
• Start date: February 2016
• Est. completion date: June 2017

Study information

• Verified date: July 2017
• Source: Complexo Hospitalario Universitario de A Coruña
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether continuous cardiac telemetry with the Pocket-ECG III® system is more useful than conventional Holter to find out the cause of syncope

Description:

Study population: adult patients with recurrent and/or with probable cardiac origin syncopes with indication of cardiac rhythm monitoring.

Estimated sample size: COLAPS trial showed that conventional 48-hours Holter and 4-weeks external loop recorder got a diagnosis in 22% and 56%, respectively, in patients with syncope. Based on this data, to compare two matched-proportions with α-risk=0.05 and β-risk=0.2, 34 patients would be needed; to compensate a 15-20% percentage of lost patients during follow-up, it is estimated that 40 patients is the number to include in the trial to demonstrate the effect.

Variables to collect:

Baseline variables: birthdate date (month, year), inclusion date, gender, number and features of syncopes, cardiovascular risk factors, electrocardiogram, type of cardiopathy, left ventricular ejection fraction, comorbidities and treatments.

Monitoring findings: diagnostic event and diagnostic fulfilled criteria, date of diagnostic event, date of last follow-up.

Safety and adverse events: monitoring length, unexpected battery depletion, number of losses of mobile phone signal, cutaneous reactions to electrodes.

Costs: the costs of every diagnostic procedure used from inclusion to the end of follow-up will be added, based on prespecified costs of every item (Decreto 56/2014 of the Consellería de Sanidade de la Xunta de Galicia, which specifies the costs of every diagnostic or therapeutic intervention in centers depending on the Servicio Gallego de Salud).

Intervention description: patients with indication of conventional Holter monitoring will be consecutively included. After signing written informed consent, a Pocket-ECG III® system will be given to the patient. All participants will be monitored by the Pocket-ECG III® system until a diagnosis is achieved or for a maximum of two months (whatever it happens first). Everyday daily reports sent via e-mail by the manufacturer company (MEDICALgorithmics© S.A.) will be reviewed by the investigator team; in case of a diagnosis event (according to prespecified diagnostic criteria from the European Society of Cardiology), appropriate treatment will be applied.

Every patient will be his/her own control. Conventional 24-hours Holter monitoring will be simulated using data obtained by the Pocket-ECG III® system in the first 24 hours, ignoring the registries of the rest of days. Two and Three 24-hours conventional Holter strategies will also be simulated analyzing data from first 24 hours and 1-2 additional days, respectively, chosen by means of a random number creation system which will identify the days of registry to be considered. Diagnostic criteria in this virtual control group will be the same as used in the actual Pocket-ECG III® system monitoring group.

Follow-up: patients will be followed-up by two complementary manners

1. Real-time remote: Pocket-ECG III® system sends continuously the registered electrocardiogram sinal via GSM mobile phone to a central unit sited in Poland, where the signal is processed and interpreted. From this central unit, a daily report and a weekly summary report is sent by e-mail to the investigator team. If a lost in the mobile phone coverage happens, the system stores the registry in its memory until the coverage is recovered, when the whole stored registry is sent.

2. Purpose-created outpatient clinic.

Statistical methods: categorical variables will be expressed as "absolute number (percentage)" and continuous variables as "mean ± standard deviation", adding "median (interquartile range)" when the distribution of values is far from normal distribution assessed by Kolmogorov-Smirnov and Shapiro-Wilk methods. Proportion of diagnosis achieved by each strategy will be compared by McNemar for intrasubject measures or binomial exact methods, whichever applies. Economic burden of each strategy will be compared with the t-Student for intrasubject measures or T de Wilcoxon methods, whichever applies. All tests of significance will be 2-sided, with p<0.05 considered statistically significant. The analysis will be conducted using PASW Statistics version 18.0 (IBM, Armonk, New York) and EPIDAT 3.1 (provided by the Direccion Xeral de Saude Publica de la Consellería de Sanidade de la Xunta de Galicia).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with syncope refered to perform 24-hours conventional Holter who fulfill at least one of the following conditions:

1. =2 episodes of syncope in the last year, provided that they are not typical vasovagal syncope, and/or

2. =1 episode of syncope with any criterion of suspicion of cardiac-arrhythmic aetiology, according to current European Guidelines about management of syncope

Exclusion Criteria:

• Carrier of any cardiac implantable electronic device or internal loop recorder, as well as stablished indication for it according to current guidelines.

• Aetiologic diagnosis of syncope already known.

• Left ventricular ejection fraction =35%.

• Unability to perform the monitorization

Related Conditions & MeSH terms

• Syncope

Intervention

Device:
• Pocket-ECG III system
Continuous cardiac telemetry until diagnosis or a maximum of two months

Locations

Country	Name	City	State
Spain	Complexo Hospitalario Universitario de A Coruna	A Coruna

Sponsors (1)

Lead Sponsor	Collaborator
Complexo Hospitalario Universitario de A Coruña

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of etiology diagnosis of syncope		two months
Primary	length of time until diagnosis		two months
Primary	Overall and per diagnosis costs		Two months
Secondary	length of properly analyzable registry		two months